eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/11/2008
PIL Naropin 2 mg/ml Solution for Infusion and 2mg/ml, 7.5 mg/ml, 10 mg/ml Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/11/2008 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/10/2008 and displayed until 21/11/2008
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
Updated on 24/04/2007 and displayed until 16/10/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 29/07/2004 and displayed until 24/04/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  ropivacaine